|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal Susitarimą)
| (51) | INT.CL. | A01N 37/18 | |
| A61P 5/00 | |||
| A61K 38/30 |
| (11) | Patento numeris | 2274978 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 10009976.1 |
| Europos patento paraiškos padavimo data | 2004-09-09 | |
| (97) | Europos patento paraiškos paskelbimo data | 2011-01-19 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2015-05-20 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (30) | Numeris | Data | Šalis |
| 502579 P | 2003-09-12 | US |
| (72) |
Clark, Ross G., NZ
|
| (73) |
Ipsen Biopharmaceuticals, Inc.,
106 Allen Road, 3rd Floor, Basking Ridge, NJ 07920,
US
|
| (54) | Methods for treatment of insulin-like growth factor-I(IGF-I) deficiency |
| Methods for treatment of insulin-like growth factor-I(IGF-I) deficiency |